Amir Mehdizadeh

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

Van K. Morris, Mohamed E. Salem, Halla Nimeiri et al. · The Lancet Oncology · 2017 · 383 citations

Medicine, Immune Checkpoint Inhibitor, Surgery +4

Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer

Chang Liu, Cathy Eng, Jianjun Shen et al. · Oncotarget · 2016 · 114 citations · Full text

Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis

Sanam Dolati, Zohreh Babaloo, Hormoz Ayromlou et al. · Journal of Neuroimmunology · 2019 · 104 citations

Nanomedicine, Autoimmune Disease, Medicine +11

Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy

Roza Motavalli, Jalal Etemadi, Mohammad Sadegh Soltani‐Zangbar et al. · Cytokine · 2021 · 70 citations

Glomerular Disease, Glomerulonephritis, Renal Function +15

Metabolic syndrome mediates inflammatory and oxidative stress responses in patients with recurrent pregnancy loss

Ramyar Azizi, Mohammad Sadegh Soltani‐Zangbar, Golshan Sheikhansari et al. · Journal of Reproductive Immunology · 2019 · 61 citations

Metabolic Syndrome, Oxidative Stress Responses, Metabolic Syndrome Mediates +12